All Stories

AbbVie regained TV ad spending lead amid February slowdown, with Rinvoq and Skyrizi back on top

After Novartis’ Pluvicto shook up iSpot.TV’s monthly rankings of the top TV advertising spenders in pharma to kick off the year, it was back to business as usual in February.

Mar 12, 2025 - 17:13
 0
AbbVie regained TV ad spending lead amid February slowdown, with Rinvoq and Skyrizi back on top
After Novartis’ Pluvicto shook up iSpot.TV’s monthly rankings of the top TV advertising spenders in pharma to kick off the year, it was back to business as usual in February.
Read More

Tags:

Previous Article

Trump Ramps Up Support for Tesla and Musk At White House Event

Next Article

Orphan designation: Trehalose Treatment of neuronal ceroid lipofuscinosis, 19/10...

Related Posts

Genentech, Novartis join forces to raise awareness of food allergies’ impact on families

Genentech, Novartis join forces to raise awareness of f...

Feb 20, 2025  0

Novo Nordisk predicts milder growth in 2025 after obesity star Wegovy doubles sales in Q4

Novo Nordisk predicts milder growth in 2025 after obesi...

Feb 9, 2025  0

Lilly banks stockpile of oral GLP-1 drug with potential launch still more than a year away

Lilly banks stockpile of oral GLP-1 drug with potential...

Feb 24, 2025  0